Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-03

Clinical Trial Update: Evaluation of the NaviFUS System in Drug Resistant Epilepsy [NA]

View source ↗

Summary

Clinical trials registry update showing the NaviFUS System is being evaluated for drug-resistant epilepsy, including temporal lobe epilepsy, with recruitment on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NaviFUS System

Snippet

Sponsor: Genovate-NaviFUS (Australia) Pty Ltd. | Conditions: Epilepsy, Temporal Lobe, Drug Resistant Epilepsy | NA | Status: RECRUITING